Drug Name Alesse

On 23 October 2008, the European Medicines Agency (EMEA) issued a press release stating its Committee for Medical Products for Human Use (CHMP) had concluded the benefits of Acomplia no longer outweighed its risks, and subsequently recommended the product be suspended from the UK market. Sanofi-Aventis later released a press statement stating the drug had been suspended. Approval of the drug was officially withdrawn by the EMEA on 16 January 2009.
Sanofi-aventis announces that concerning the New Drug Application for rimonabant in the United States, the Food and Drug Administration has considered its October 26, 2006 resubmission to be a complete, class 2 response to the FDA February 17, 2006 action letter.

 

The bottom line is that if you use an HbA1c measurement as a screening test, you'll have a lot of false-negatives and some false-positives," said Mary Rhee, MD, Assistant Professor of Endocrinology at Emory University in Atlanta. And in this day and age when diabetes is a worsening public health epidemic not only in the U.S. but also around the world, we can't afford to end up with more cases of undiagnosed diabetes."
It can sometimes result in reactions that range in severity from a rash (in the case of patients that may unwittingly have mononucleosis) to potentially lethal allergic reactions such as anaphylaxis. However, as with other penicillin drugs, it is relatively non-toxic and adverse effects of a serious nature are encountered only infrequently.